Forecasting Relapse Outcomes With AlloHeme-based Risk Detection in Post-Allo-HCT AML/MDS Patients (FORWARD)

Clinical trial NCT07607327 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07607327
Sponsor: CareDx
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

AML (Acute Myelogenous Leukemia)MDS (Myelodysplastic Syndrome)CMML

Start date: 2026-08-31
Primary completion: 2029-12-31
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.